The 20 Best HIV/AIDS Doctors Near Me

Harry Janssen practices in Rotterdam, Netherlands. Mr. Janssen is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis B, Hepatitis, Primary Biliary Cholangitis, Liver Transplant, and Mastectomy.

Edward Gane practices in Grafton, New Zealand. Mr. Gane is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, Liver Transplant, and Kidney Transplant.

Andrea Antinori practices in Rome, Italy. Ms. Antinori is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, COVID-19, Hepatitis, and Monkeypox.

Jacques Izopet practices in Toulouse, France. Mr. Izopet is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis E, Hepatitis, Hereditary Neuralgic Amyotrophy, Kidney Transplant, and Liver Transplant.

Cristina Mussini practices in Modena, Italy. Ms. Mussini is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Sepsis, COVID-19, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

Jordan Feld practices in Toronto, Canada. Mr. Feld is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis, Hepatitis C, Hepatitis B, Liver Transplant, and Lung Transplant.

Jurgen Rockstroh practices in Koeln, Germany. Mr. Rockstroh is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Hepatitis C, Hepatitis, Cirrhosis, and Liver Transplant.

Pietro Lampertico practices in Milan, Italy. Mr. Lampertico is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis D, Hepatitis, Hepatitis B, Liver Transplant, and Endoscopy.

Vincent Wong practices in Sha Tin, Hong Kong Special Administrative Region. Mr. Wong is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Hepatitis B, Hepatitis, Liver Transplant, and Hepatectomy.

Wei Li practices in Yancheng, China. Li is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. Their top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Stroke, Endoscopy, and Thrombectomy.

Grace Wong practices in Sha Tin, Hong Kong Special Administrative Region. Ms. Wong is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are Hepatitis B, Hepatitis, Cirrhosis, Hepatectomy, and Liver Transplant.

Yasuhito Tanaka practices in Kumamoto, Japan. Tanaka is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. Their top areas of expertise are Hepatitis, Hepatitis B, Hepatitis C, Osteotomy, and Liver Transplant.

Philip Rosenthal is a Pediatric Gastroenterologist in San Francisco, California. Dr. Rosenthal is rated as an Elite provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Alagille Syndrome, Biliary Atresia, Cholestasis, Hepatitis, and Liver Transplant.

Graeme Meintjes practices in Cape Town, South Africa. Mr. Meintjes is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Cryptococcosis, Cryptococcal Meningitis, Meningitis, and HIV/AIDS.

Giovanni Guaraldi practices in Modena, Italy. Mr. Guaraldi is rated as an Elite expert by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, COVID-19, Non-Alcoholic Fatty Liver Disease, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

Mark Sulkowski, MD, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine and is the Senior Associate Dean for Clinical Trials. He received his MD from Temple University School of Medicine, Philadelphia, PA (1992), pursued training in Internal Medicine at Duke University School of Medicine, Durham, NC (1995) and completed his Fellowship in Infectious Diseases (1998) at the Johns Hopkins University School of Medicine. Prof. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. He was the global principal investigator for more than a dozen trials, including the largest clinical trial of agents for the treatment of hepatitis C (New England Journal of Medicine, 2009) and the vanguard study of combination therapy with direct inhibitors of the HCV NS5A and NS5B non-structural proteins (New England Journal of Medicine, 2014). He is the past-chair of the Hepatitis Transformative Sciences Group of the National Institute of Health-funded adult AIDS Clinical Trials Group (ACTG) where he led translational studies of liver disease, namely hepatitis B and C virus. He is an elected member of the American Society for Clinical Investigation (2011) and the American Association of Physicians (2017). Prof. Sulkowski is a member of numerous professional societies including the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), and the Infectious Diseases Society of America (IDSA). With more than 300 peer-reviewed articles, he is widely published with works in Annals of Internal Medicine, New England Journal of Medicine, JAMA, Clinical Infectious Diseases, Journal of Hepatology, and Hepatology. In 2017, 2018 and 2019, he was named as a Highly Cited Researcher (Clarivate Analytics) defined as the being in the top 1% of global researchers in 21 fields of the sciences and social sciences based on the number of citations for papers. As an invited lecturer, he has been frequently invited to present at major national and international medical congresses and has educated learners in more than 25 countries. Dr. Sulkowski is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Hepatitis B.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), where he holds the Bruce and Robert Beal Distinguished Chair, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, did his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital.He is Editor-in-Chief of Open Forum Infectious Diseases, is Section Editor of HIV/AIDS in UpToDate, on the Editorial Board of NEJM Journal Watch Infectious Diseases (where he writes the HIV and ID Observations blog), and on the editorial advisory board of Medscape HIV/AIDS. Dr. Sax is the Associate Program Director for the Mass General Brigham fellowship in Infectious Diseases, is on the core faculty of the International Antiviral Society – USA, and teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice and teaching, Dr. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group. Dr. Sax is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dementia Complex.

Pablo Tebas is an Infectious Disease provider in Philadelphia, Pennsylvania. Dr. Tebas is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dementia Complex. Dr. Tebas is currently accepting new patients.

Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School.  He completed his clinical and research training in internal medicine and infectious diseases at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center.  Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is now the Harriet Ryan Albee Professor of Medicine and Chief, Division of Infectious Diseases at Brigham and Women’s Hospital.  Dr. Kuritzkes has published extensively on antiretroviral therapy and drug resistance in HIV-1 infection.  He has chaired several multicenter studies of HIV therapy and previously chaired the AIDS Clinical Trials Group.  He has served on numerous NIH committees, including as a member of the NIH Office of AIDS Research Advisory Council.  He is a former member of the Department of Health and Human Services panel on guidelines for antiretroviral therapy and a past Chair of the HIV Medicine Association Board of Directors.  He has been a member of several editorial boards, and serves as an Associate Editor of the Journal of Infectious Diseases.  His research interests focus on HIV therapeutics, antiretroviral drug resistance, HIV eradication and more recently, COVID-19. Dr. Kuritzkes is rated as a Distinguished provider by MediFind in the treatment of HIV/AIDS. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.